Stigmurin [S3,7K;G10K], StigA16

General Information


DRACP ID  DRACP03694

Peptide Name   Stigmurin [S3,7K;G10K], StigA16

Sequence  FFKLIPKLVKGLISAFK

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C99H161N21O19

Absent amino acids  CDEHMNQRTWY

Common amino acids  K

Mass  223507

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  10

Net charge  4

Boman Index  1473

Hydrophobicity  96.47

Aliphatic Index  137.65

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29670004

Title  Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11271

DRACP is developed by Dr.Zheng's team.